SB 1804 — Prohibits certain professional licensing boards from waiving or modifying administrative rules related to prescription authority
Last action — Second Read and Referred S Emerging Issues and Professional Registration Committee
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill is in committee in the Senate. Introduced February 26, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the Senate.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
In Committee
Current position in the legislative process.
-
1 sponsor
1 primary, 0 co-sponsors signed on.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
Summary
SB 1804 - This act provides that certain professional licensing boards shall not grant any regulatory mitigation or waive or modify any rules related to dispensing, prescribing, administering, or otherwise distributing, including renewing, medications or controlled substances to a person or business developing, creating, or generating artificial intelligence for such prescription activities. KATIE O'BRIEN
Bill Text
- Introduced 7472S.01I - Introduced Current pdf
Action History
-
Second Read and Referred S Emerging Issues and Professional Registration Committee
-
S First Read
Sponsors
- Doug Beck · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 198 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (198)
198 members have not signed on to this bill.
Show all 198 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 1804 do?
- SB 1804 - This act provides that certain professional licensing boards shall not grant any regulatory mitigation or waive or modify any rules related to dispensing, prescribing, administering, or otherwise distributing, including renewing, medications or controlled substances to a person or business developing, creating, or generating artificial intelligence for such prescription activities. KATIE O'BRIEN
- Who sponsors SB 1804?
- SB 1804 is sponsored by Doug Beck.
- What is the current status of SB 1804?
- This bill is in committee in the Senate. Introduced February 26, 2026. It must pass committee before a floor vote.
- Where can I track SB 1804?
- Track SB 1804 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 1804
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 1804
Last checked for changes about 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →